110 related articles for article (PubMed ID: 10627170)
1. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
[No Abstract] [Full Text] [Related]
2. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.
Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T
Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
Murray S; Odupitan AO; Murray BP; Boobis AR; Edwards RJ
Xenobiotica; 2001 Mar; 31(3):135-51. PubMed ID: 11465391
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.
Thijssen HH; Flinois JP; Beaune PH
Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154
[TBL] [Abstract][Full Text] [Related]
5. Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase.
Draper AJ; Hammock BD
Arch Biochem Biophys; 2000 Apr; 376(1):199-205. PubMed ID: 10729206
[TBL] [Abstract][Full Text] [Related]
6. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
Tang C; Shou M; Rodrigues AD
Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
[TBL] [Abstract][Full Text] [Related]
7. A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.
Ohyama K; Nakajima M; Nakamura S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 2000 Nov; 28(11):1303-10. PubMed ID: 11038157
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
Grimm SW; Dyroff MC
Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
[TBL] [Abstract][Full Text] [Related]
9. Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates.
Mankowski DC; Lawton MP; Ekins S
Xenobiotica; 2000 Aug; 30(8):745-54. PubMed ID: 11037108
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9.
Jones JP; He M; Trager WF; Rettie AE
Drug Metab Dispos; 1996 Jan; 24(1):1-6. PubMed ID: 8825183
[No Abstract] [Full Text] [Related]
11. Substrate influence on interaction between cytochrome P450 and cytochrome b5 in microsomes.
Jansson I; Schenkman JB
Arch Biochem Biophys; 1996 Jan; 325(2):265-9. PubMed ID: 8561506
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P4502C11 is a target of diclofenac covalent binding in rats.
Shen S; Hargus SJ; Martin BM; Pohl LR
Chem Res Toxicol; 1997 Apr; 10(4):420-3. PubMed ID: 9114979
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
Miller JL; Trepanier LA
Eur J Clin Pharmacol; 2002 Apr; 58(1):69-72. PubMed ID: 11956677
[TBL] [Abstract][Full Text] [Related]
14. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
Klekotka PA; Halpert JR
Drug Metab Dispos; 1995 Dec; 23(12):1434-5. PubMed ID: 8689957
[No Abstract] [Full Text] [Related]
15. Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions.
Karjalainen MJ; Neuvonen PJ; Backman JT
Drug Metab Dispos; 2006 Dec; 34(12):2091-6. PubMed ID: 16985100
[TBL] [Abstract][Full Text] [Related]
16. Effect of fluvoxamine on the pharmacokinetics of quinidine.
Damkier P; Hansen LL; Brøsen K
Eur J Clin Pharmacol; 1999 Aug; 55(6):451-6. PubMed ID: 10492058
[TBL] [Abstract][Full Text] [Related]
17. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
18. [Diminished activity of testosterone-16-alpha hydroxylase in bovine liver microsomes].
Depelchin BO
Ann Rech Vet; 1984; 15(4):515-8. PubMed ID: 6529121
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.
Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K
Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine is a potent inhibitor of cytochrome P4501A2.
Brøsen K; Skjelbo E; Rasmussen BB; Poulsen HE; Loft S
Biochem Pharmacol; 1993 Mar; 45(6):1211-4. PubMed ID: 8466541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
